London G M, Blacher J, Pannier B, Guérin A P, Marchais S J, Safar M E
Service d'Hémodialyse, Hôpital F.H. Manhès, Fleury-Mérogis, Ste-Geneviève-des-Bois, France.
Hypertension. 2001 Sep;38(3):434-8. doi: 10.1161/01.hyp.38.3.434.
The increased effect of arterial wave reflections on central arteries like the common carotid artery seen in end-stage renal failure (ESRF) patients favors myocardial hypertrophy and oxygen consumption and alters coronary blood flow distribution. Nevertheless, the impact of wave reflection on the outcome and end points such as mortality remains to be demonstrated. One hundred eighty ESRF patients (age, 54+/-16 years) were monitored for 52+/-36 months (mean+/-SD). Seventy deaths, including 40 cardiovascular (CV) and 30 non-CV events, occurred. At entry, patients, in addition to standard clinical and biochemical analyses, underwent aortic pulse wave velocity measurement and determination of arterial wave reflexion by applanation tonometry on the common carotid artery that was expressed as augmentation index. Cox analyses demonstrated that predictors of all-cause and CV mortality were age, aortic pulse wave velocity, low diastolic blood pressure, preexisting CV disease, and increased augmentation index, whereas the prescription of an ACE inhibitor had a favorable effect on survival. After adjustment for all confounding factors, the risk ratio for each 10% increase in augmentation index was 1.51 (95% confidence interval, 1.23 to 1.86; P<0.0001) for all-cause mortality and 1.48 (95% confidence interval, 1.16 to 1.90; P<0.0001) for CV mortality. These results provide the first direct evidence that in ESRF patients increased effect of arterial wave reflections is an independent predictor of all-cause and CV mortality.
在终末期肾衰竭(ESRF)患者中,动脉波反射对诸如颈总动脉等中心动脉的增强作用有利于心肌肥大和氧消耗,并改变冠状动脉血流分布。然而,波反射对诸如死亡率等结局和终点的影响仍有待证实。对180例ESRF患者(年龄54±16岁)进行了52±36个月(均值±标准差)的监测。发生了70例死亡,包括40例心血管(CV)事件和30例非CV事件。入院时,患者除了进行标准的临床和生化分析外,还接受了主动脉脉搏波速度测量,并通过对颈总动脉进行压平式眼压测量来确定动脉波反射,以增强指数表示。Cox分析表明,全因死亡率和CV死亡率的预测因素包括年龄、主动脉脉搏波速度、低舒张压、既往CV疾病和增强指数增加,而使用ACE抑制剂对生存有有利影响。在对所有混杂因素进行调整后,增强指数每增加10%,全因死亡率的风险比为1.51(95%置信区间,1.23至1.86;P<0.0001),CV死亡率的风险比为1.48(95%置信区间,1.16至1.90;P<0.0001)。这些结果提供了首个直接证据,表明在ESRF患者中,动脉波反射的增强作用是全因死亡率和CV死亡率的独立预测因素。